Evaluation of the serologic test cobas core anti-h.pylori EIA in the diagnosis of helicobacter pylori infection / (Record no. 3474)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02322nam a22002057a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DOH |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20210312144149.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210312b ||||| |||| 00| 0 eng d |
| 245 00 - TITLE STATEMENT | |
| Title | Evaluation of the serologic test cobas core anti-h.pylori EIA in the diagnosis of helicobacter pylori infection / |
| Statement of responsibility, etc. | Venancio I. Gloria [and three others] |
| 520 3# - SUMMARY, ETC. | |
| Summary, etc. | Objective: to determine the validity of the Cobas Core Anti-H. pylori EIA serologic test in the diagnosis of helicobacter pylori infection in an independent and blind comparison with histology of gastric antrum biopsy specimens as the gold standar. Design: Cross-sectional standard criterion study. Setting: The study was conducted at the Out Patient Department Endoscopy Unit of UP-PGH, tertiary care Hospital. Patients/Participants: Three hundred (300) consecutive patients who satisfied the following inclusion and exclusion criteria: 10 male or female age 18-80 years with indications for upper gutendoscopy; (2) with written informed consent to be included in the study (in all aspects) and to undergo upper gut endoscopy with biopsy. Exclusion Criteria: 1) intake of antibiotics, bismuth compund. H2 blockers or proton pump inhibitors within 4 weeks prior entry; 2) prevous resective gastric surgery; 3) pregnancy; 4) caustic ingestion; 5)illness or other contraindications that preclude safe endoscopy. Interventions: all included patients were subjected to two interventions: 1) upper gut endoscopy with biopsy of the gastric antrum for histologic examination: and 2) blood extraction of five (5) milliliter for the serologic test. Main Outcome Measures: Sensitivity, specificity, likelihood ratios were calculated for the serologic test and the prevalence rate of H. pylori in the study was likewise determined. Results: The sensitivity and the specificity for the serologic test were 89.25% and 80.70% respectively. Likelihood ratios, positive and negative, for the same test were 4.62 and 0.13, respectively. Prevalence rate of H.pylori was 62.0%. |
| 580 ## - LINKING ENTRY COMPLEXITY NOTE | |
| Linking entry complexity note | Acta Medica Philippina, 2000 36 ( 1&2 ) pages 27-33 |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Helicobacter pylori |
| 650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Serologic Tests |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gloria, Venancio I. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Daez, Ma. Lourdes O. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fernandez, Arnold |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dimacali, Andrew D. |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Koha item type | Journal Article |
| 999 ## - | |
| -- | 3474 |
| -- | 3474 |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National Library of Medicine | DOH Central Library | DOH Central Library | Electronic Resource Section | 03/12/2021 | J000160 | D0001J000160 | 03/12/2021 | 03/12/2021 | Journal Article |